Archives

Loading Events

Autosomal Dominant Polycystic Kidney Disease (ADPKD): Disease Progression

This presentation, Autosomal Dominant Polycystic Kidney Disease (ADPKD): Disease Progression, will discuss various risk-assessment tools to help identify patients at risk for rapid progression of the disease.

This is a Regional Virtual Live Event in collaboration with the Ohio Association of Advanced Practice Nurses (OAAPN).

*Speakers are employees of Otsuka Pharmaceutical Development & Commercialization, Inc (OPDC).

This event is Private.
Featured Speakers
Jill A Green

Jill A Green, PhD

Nephrology Clinical & Scientific Director
    Otsuka Pharmaceutical Development & Commercialization, Inc.*

Jill A Green, PhD, is a Senior Medical Science Liaison in the nephrology division at Otsuka Pharmaceutical Development & Commercialization, Inc. Dr Green received her PhD in biomedical sciences, with a specialization in biochemical and molecular basis of disease. She went on to hold a research scientist role at The James Comprehensive Cancer Center at The Ohio State University, specializing in oncology pre-clinical research before taking a position as a Regulatory Compliance Officer where she managed thoracic oncology clinical trials at The James Cancer Hospital.

Dr Green has been a proud member of the PKD Foundation – Columbus, OH chapter for over 12 years where she has been active in fundraising and advocacy efforts.

Geoffrey Lockwood

Geoffrey Lockwood, PharmD, BCPS, MBA

Nephrology Senior Clinical & Scientific Liaison
    Otsuka Pharmaceutical Development & Commercialization, Inc.*

Geoffrey Lockwood, PharmD, BCPS, MBA is a clinical pharmacist who works as a Medical Science Liaison with Otsuka Pharmaceutical Development & Commercialization, Inc. He has been in his current role for 2 years, supporting Nephrology. Prior to joining Otsuka, he worked as an Emergency Medicine and Critical Care Clinical Pharmacist at Spectrum Health Butterworth Hospital in Grand Rapids, Michigan. Dr Lockwood earned his Doctor of Pharmacy Degree from Ferris State University in Big Rapids, Michigan. Dr Lockwood completed a PGY-1 Pharmacy Practice Residency with Christus Spohn Health System in Corpus Christi, Texas. Upon completion of residency, Dr. Lockwood worked as a Critical Care Clinical Pharmacy Specialist with Christus Spohn Memorial Hospital in Corpus Christi, Texas. He then moved to South Bend, Indiana where he took on the role of Clinical Pharmacy and Pharmacy Residency Program Coordinator at Memorial Hospital of South Bend. Dr Lockwood then moved to Elkhart General Hospital where he started the Emergency Medicine Clinical Pharmacy Program and served as an Emergency Medicine Clinical Pharmacy Specialist. Dr Lockwood is currently working to complete his MBA with a Value-Driven Organization emphasis through Central Michigan University. Dr Lockwood is board certified in pharmacotherapy and is a licensed pharmacist in the states of Michigan and Indiana.

Katherine Maringer

Katherine Maringer, PhD

Nephrology Medical Science Liaison
    Otsuka Pharmaceutical Development & Commercialization, Inc.*

Katherine Maringer, PhD is a molecular biologist who works for Otsuka as a Medical Science Liaison. Her areas of expertise include nephrology, chronic kidney disease, kidney development, histology, cell signaling, and molecular biology. Before becoming a Medical Science Liaison, Dr. Maringer was an NIDDK funded postdoctoral fellow at both University of Pittsburgh-Renal Electrolyte Division, and Children’s Hospital of Pittsburgh-Nephrology, specializing in molecular and cellular signaling during kidney injury and disease. Dr. Maringer’s alma mater is the University of Arkansas at Little Rock.

Location

Online via NephU.org